JAMA Oncology Author Interviews
Episodes
Metastatic Recurrence Among Adolescents and Young Adults With Cancer
26 Nov 2025
Contributed by Lukas
Interview with Ann Brunson, MS, and Theresa H. M. Keegan, PhD, MS, authors of Metastatic Recurrence Among Adolescents and Young Adults With Cancer. Ho...
Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality
30 Oct 2025
Contributed by Lukas
Interview with Yiwen Zhang, PhD, and Edward L. Giovannucci, MD, ScD, authors of Consistent Adherence to Physical Activity Guidelines and Digestive Sys...
Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer
18 Sep 2025
Contributed by Lukas
Interview with Jiyoung Ahn, PhD, author of Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer. Hosted by Vivek Subbiah, MD...
Proportional Sedation for Persistent Agitated Delirium in Palliative Care
31 Jul 2025
Contributed by Lukas
Interview with David Hui, MD, and Eduardo Bruera, MD, authors of Proportional Sedation for Persistent Agitated Delirium in Palliative Care: A Randomiz...
New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance
29 May 2025
Contributed by Lukas
Interview with Thorir Einarsson Long, MD, PhD, and Ola Landgren, MD, PhD, authors of New Definition of Light Chain Monoclonal Gammopathy of Undetermin...
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury
24 Apr 2025
Contributed by Lukas
Interview with Shruti Gupta, MD, MPH, author of Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury. Hosted by Vivek Subbiah, MD. Rela...
Accelerated Aging in Survivors of Childhood Cancer
20 Mar 2025
Contributed by Lukas
Interview with Jennifer M. Yeh, PhD, and Lisa R. Diller, MD, authors of Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Ri...
Academic-Community Partnership and Deaths in Promyelocytic Leukemia
27 Feb 2025
Contributed by Lukas
Interview with Anand P. Jillella, MD, author of Academic-Community Partnership and Deaths in Promyelocytic Leukemia: The Nonrandomized ECOG-ACRIN EA91...
Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy
30 Jan 2025
Contributed by Lukas
Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on An...
Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020
05 Dec 2024
Contributed by Lukas
Interview with Katrina A. B. Goddard, PhD, author of Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020....
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
21 Nov 2024
Contributed by Lukas
Interview with Hagop Kantarjian, MD, author of Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1...
Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
24 Oct 2024
Contributed by Lukas
Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomi...
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
05 Sep 2024
Contributed by Lukas
Interview with Eileen M. O’Reilly, MD, author of Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer. Hosted by Vivek Subbiah, MD...
Identification of Immune Checkpoint Inhibitor–Induced Diabetes
29 Aug 2024
Contributed by Lukas
Interview with Michelle Rengarajan, MD, PhD, author of Identification of Immune Checkpoint Inhibitor–Induced Diabetes. Hosted by Vivek Subbiah, MD. ...
Neoadjuvant Exercise Therapy in Prostate Cancer
18 Jul 2024
Contributed by Lukas
Interview with Lee W. Jones, PhD, author of Neoadjuvant Exercise Therapy in Prostate Cancer: A Phase 1, Decentralized Nonrandomized Controlled Trial. ...
Endometrial Thickness as Diagnostic Triage for Endometrial Cancer in Black Individuals
27 Jun 2024
Contributed by Lukas
Interview with Kemi M. Doll, MD, MSCR, author of Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals. Hosted by ...
T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
18 Apr 2024
Contributed by Lukas
Interview with Roni Shouval, MD, PhD, author of T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. Hosted by Vivek Subbiah, MD...
Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time
21 Mar 2024
Contributed by Lukas
Interview with Tobias Janowitz, MD, PhD, and Karen Winkfield, MD, PhD, authors of Analysis and Optimization of Equitable US Cancer Clinical Trial Cent...
Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer
29 Feb 2024
Contributed by Lukas
Interview with José P. Leone, MD, author of Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer. Hoste...
Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US
04 Jan 2024
Contributed by Lukas
Interview with Sajid A. Khan, MD, author of Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. Hosted by Mary L...
Atezolizumab in Combination With Carboplatin in Metastatic TNBC
14 Dec 2023
Contributed by Lukas
Interview with Jennifer A. Pietenpol, PhD, Brian D. Lehmann, PhD, and Vandana G. Abramson, MD, authors of Atezolizumab in Combination With Carboplatin...
Shorter-Course Radiotherapy for Prostate Cancer
05 Oct 2023
Contributed by Lukas
Interview with Daniel E. Spratt, MD, author of Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer. Hosted by Jack West, MD. Related Co...
Sentinel Lymph Node Biopsy vs No Axillary Procedure in Small Node-Negative Breast Cancer
21 Sep 2023
Contributed by Lukas
Interview with Oreste Davide Gentilini, MD, author of Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negat...
A Geospatial Analysis of Disparities in Access to Oncofertility Services
10 Aug 2023
Contributed by Lukas
Interview with Kara N. Goldman, MD, author of A Geospatial Analysis of Disparities in Access to Oncofertility Services. Hosted by Jack West, MD. Rela...
Integrated Clinical-Molecular Classification of Colorectal Liver Metastases
20 Jul 2023
Contributed by Lukas
Interview with Sean P. Pitroda, MD, author of Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the...
US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020
29 Jun 2023
Contributed by Lukas
Interview with Sophia C. Kamran, MD, author of US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020. Hosted by Jack West, MD. Rela...
Oncolytic Viral Immunochemotherapy in Patients With Ovarian Cancer
25 May 2023
Contributed by Lukas
Interview with Robert W. Holloway, MD, and Sarfraz Ahmad, PhD, authors of Clinical Activity of Olvimulogene Nanivacirepvec–Primed Immunochemotherapy...
Radiosurgery of Spine Metastasis—NRG/RTOG 0631 RCT Final Results
20 Apr 2023
Contributed by Lukas
Interview with Samuel Ryu, MD, author of Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase...
Pathologic Complete Response and Clinical Outcomes in Soft Tissue Sarcoma
30 Mar 2023
Contributed by Lukas
Interview with Dian Wang, MD, author of Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With...
Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma
16 Feb 2023
Contributed by Lukas
Interview with Laura A. Bolte, MSc, Geke A. P. Hospers, MD, PhD, and Rinse K. Weersma, MD, PhD, authors of Association of a Mediterranean Diet With Ou...
Adoption of Innovative Therapies Across Oncology Practices
05 Jan 2023
Contributed by Lukas
Interview with Nancy L. Keating, MD, MPH, author of Adoption of Innovative Therapies Across Oncology Practices—Evidence From Immunotherapy. Hosted b...
Adjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy
08 Dec 2022
Contributed by Lukas
Interview with Marco Del Chiaro, MD, PhD, author of Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Mul...
Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma
17 Nov 2022
Contributed by Lukas
Interview with Linda M. Liau, MD, PhD, author of Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival A...
Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma
27 Oct 2022
Contributed by Lukas
Interview with Olivier J. van Not, MD, and Karijn P. M. Suijkerbuijk, MD, PhD, authors of Association of Immune-Related Adverse Event Management With ...
Prostate-Specific Antigen Screening Rates and Metastatic Prostate Cancer Incidence in the VHA
24 Oct 2022
Contributed by Lukas
Interview with Brent S. Rose, MD, author of Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incide...
Therapy and Survival Patterns in Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy
18 Aug 2022
Contributed by Lukas
Interview with Hagen F. Kennecke, MD, author of Patterns of Practice and Improvements in Survival Among Patients With Stage 2/3 Rectal Cancer Treated ...
Global Association of COVID-19 Pandemic Measures With Cancer Screening
07 Jul 2022
Contributed by Lukas
Interview with Paolo Boffetta, MD, author of Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-anal...
A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief
05 Jul 2022
Contributed by Lukas
In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with...
High TMB in NSCLC and Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade
16 Jun 2022
Contributed by Lukas
Interview with Mark M. Awad, MD, PhD, author of Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infil...
Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality
19 May 2022
Contributed by Lukas
Interview with Lars Björnebo, MSc, and Anna Lantz, MD, PhD, authors of Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality. Hoste...
Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
28 Apr 2022
Contributed by Lukas
Interview with David Anthony Palma, MD, PhD, and Anthony C. Nichols, MD, authors of Assessment of Toxic Effects and Survival in Treatment Deescalatio...
Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer
17 Mar 2022
Contributed by Lukas
Interview with Kenneth L. Kehl, MD, MPH, author of Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lun...
Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer
17 Feb 2022
Contributed by Lukas
Interview with Ruth C. Carlos, MD and Gelareh Sadigh, MD, authors of Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor–...
Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy
20 Jan 2022
Contributed by Lukas
Interview with Laurent Dercle, MD, PhD, author of Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel...
Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
23 Dec 2021
Contributed by Lukas
Interview with Robert J. Motzer, MD, author of Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Pl...
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer
18 Nov 2021
Contributed by Lukas
Interview with Emmanouil Fokas, MD, DPhil, author of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for P...
Clinical Outcomes and Toxic Effects of Single-Agent ICI Treatment Among Geriatric Patients With Cancer
04 Nov 2021
Contributed by Lukas
Interview with Abdul Rafeh Naqash, MD, and Caroline A. Nebhan, MD, PhD, authors of Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpo...
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-Risk Breast Cancer
16 Sep 2021
Contributed by Lukas
Interview with Laura J. Esserman, MD, and W. Fraser Symmans, MD, authors of Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvan...
Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With NSCLC
12 Aug 2021
Contributed by Lukas
Interview with Puneeth Iyengar, MD, PhD, author of Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/...
Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer
01 Jul 2021
Contributed by Lukas
Interview with Carsten Finke, MD, and Frederik Bartels, MD, authors of Association Between Neuronal Autoantibodies and Cognitive Impairment in Patien...
Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in ERBB2-Positive Breast Cancer
24 Jun 2021
Contributed by Lukas
Interview with Thomas Hatschek, MD, PhD, author of Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2...
Efficacy and Safety of Stereotactic Radiosurgery for Brainstem Metastases
13 May 2021
Contributed by Lukas
Interview with David R. Raleigh, MD, PhD, and William C. Chen, MD, authors of Efficacy and Safety of Stereotactic Radiosurgery for Brainstem Metastas...
Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint–Based Therapy in Patients With Advanced NSCLC
15 Apr 2021
Contributed by Lukas
Interview with Charu Aggarwal, MD, and Lova Sun, MD, authors of Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoin...
Chronic Toxic Effects Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma
25 Mar 2021
Contributed by Lukas
Interview with Douglas B. Johnson, MD, author of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected ...
Anti–PD-1 Immunotherapy in Microsatellite-Stable Tumors With 10 or More Mutations per Megabase
18 Feb 2021
Contributed by Lukas
Interview with Luc GT Morris, MD MSc, author of Response Rates to Anti–PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mut...
Virtual Care Across a Tertiary Cancer Center During COVID-19
07 Jan 2021
Contributed by Lukas
Interview with Alejandro Berlin, MD, MSc, author of Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19
Osteonecrosis of the Jaw in Patients Receiving Zoledronic Acid for Bone Metastases
17 Dec 2020
Contributed by Lukas
Interview with Catherine Van Poznak, MD, author of Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Pati...
Discontinuation of Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
12 Nov 2020
Contributed by Lukas
Interview with Ehab Atallah, MD, author of Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leuke...
Association of Measurable Residual Disease With Survival in Patients With Acute Myeloid Leukemia
08 Oct 2020
Contributed by Lukas
Interview with Farhad Ravandi, MD, author of Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemi...
Survival and Adjuvant Chemotherapy in Early-Stage NSCLC With vs Without Clinicopathologic Features
17 Sep 2020
Contributed by Lukas
Interview with Daniel J Boffa, MD, author of Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non–Small Cell Lung...
Tailoring Intensity of Surveillance for Prostate Cancer Based on Prediction of Risk Stability
27 Aug 2020
Contributed by Lukas
Interview with Matthew R. Cooperberg, MD MPH, author of Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualiz...
Presence of ctDNA and CTCs After Chemotherapy and Recurrence of Triple-Negative Breast Cancer
09 Jul 2020
Contributed by Lukas
Interview with Bryan P. Schneider, MD, and Milan Radovich, PhD, authors of Association of Circulating Tumor DNA and Circulating Tumor Cells After Neo...
Association of Sedentary Behavior With Cancer Mortality in Middle-aged and Older US Adults
18 Jun 2020
Contributed by Lukas
Interview with Susan C. Gilchrist, MD, MS, author of Association of Sedentary Behavior With Cancer Mortality in Middle-aged and Older US Adults
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases
04 Jun 2020
Contributed by Lukas
Interview with Chad G. Rusthoven, MD, author of Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Me...
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
16 Apr 2020
Contributed by Lukas
Interview with Charles Dolladille, MD, author of Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy for Metastatic NSCLC
09 Apr 2020
Contributed by Lukas
Interview with Naiyer A. Rizvi, MD, author of Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic ...
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
13 Feb 2020
Contributed by Lukas
Interview with Nima Sharifi, M.D., author of HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
Cost Transparency for Prostate Cancer Radiation Therapy at National Cancer Institute–Designated Cancer Centers
16 Jan 2020
Contributed by Lukas
Interview with Trevor J. Royce, MD MS MPH, author of Analysis of Price Transparency via National Cancer Institute–Designated Cancer Centers’ Char...
Association Between BMI and Overall Survival in Advanced Non–Small Cell Lung Cancer
26 Dec 2019
Contributed by Lukas
Interview with Ganessan Kichenadasse, MBBS, FRACP, author of Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibito...
The Role of Maintenance Strategies in Metastatic Colorectal Cancer
19 Dec 2019
Contributed by Lukas
Interview with Mohamad Bassam Sonbol, M.D., author of The Role of Maintenance Strategies in Metastatic Colorectal Cancer: A Systematic Review and Net...
Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer
03 Oct 2019
Contributed by Lukas
Interview with Ranhjit Manchanda, MD, author of A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
12 Sep 2019
Contributed by Lukas
Interview with David J. Pinato, MD, author of Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor The...
Women’s Representation Among Lead Investigators of Clinical Trials in Oncology
08 Aug 2019
Contributed by Lukas
Interview with Emma B. Holliday, MD, author of Women’s Representation Among Lead Investigators of Clinical Trials in Oncology
Five-Year Survival Among Patients With Advanced Skin, Renal, and Lung Cancer Treated With Nivolumab
25 Jul 2019
Contributed by Lukas
Interview with Suzanne L. Topalian, author of Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–...
Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers
27 Jun 2019
Contributed by Lukas
Interview with Melinda C. Aldrich, author of Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers
Prognostic Potential of Circulating Tumor DNA Measurement in Nonmetastatic Colorectal Cancer
09 May 2019
Contributed by Lukas
Interview with Jeanne Tie, author of Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorec...
Single-Fraction Stereotactic vs Multifraction Radiotherapy for Pain Relief in Patients With Nonspine Bone Metastases
18 Apr 2019
Contributed by Lukas
Interview with Quynh-Nhu Nguyen, M.D., author of Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients ...
The Role of Disease Label in Patient Perceptions and Treatment Decisions in the Setting of Low-Risk Malignant Neoplasms
21 Mar 2019
Contributed by Lukas
Interview with David Urbach, author of The Role of Disease Label in Patient Perceptions and Treatment Decisions in the Setting of Low-Risk Malignant ...
Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer
21 Feb 2019
Contributed by Lukas
Interview with David A. Palma, MD, PhD, author of Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–...
Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation
10 Jan 2019
Contributed by Lukas
Interview with Joseph M. Unger, PhD, author of Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation
Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal BMI
06 Dec 2018
Contributed by Lukas
Interview with Andrew J. Dannenberg, MD, author of Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass In...
Surgery vs Radiotherapy in the Management of Gleason Score 9-10 Prostate Cancer and the Risk of Mortality
15 Nov 2018
Contributed by Lukas
Interview with Anthony D'Amico, MD, PhD, author of Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Ris...
Analgesic Use and Risk of Ovarian Cancer in the Nurses’ Health Studies
04 Oct 2018
Contributed by Lukas
Interview with Mollie E. Barnard, ScD, and Shelley Tworoger, PhD, authors of Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses’...
Hyperprogressive Disease in Patients With Advanced NSCLC Treated With PD-1/PD-L1 Inhibitors
06 Sep 2018
Contributed by Lukas
Interview with Benjamin Besse, MD, author of Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 ...
Maintenance Treatment and Survival in Patients With Myeloma
09 Aug 2018
Contributed by Lukas
Interview with Francesca Gay, author of Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis
Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Breast Cancer Screening
05 Jul 2018
Contributed by Lukas
Interview with Nora Pashayan, BSc MSc MSt MD PhD FFPH, author of Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast...
Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade
14 Jun 2018
Contributed by Lukas
Interview with Aaron Goodman, MD, author of Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors
Outcomes of Multiple-Gene Sequencing After Diagnosis of Breast Cancer
10 May 2018
Contributed by Lukas
Interview with Allison W. Kurian, M.D., M.Sc., author of Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast...
Association of Colon Cancer Survival With ACS Guideline Adherence
12 Apr 2018
Contributed by Lukas
Interview with Erin L. Van Blarigan, ScD, and Jeffrey A Meyerhardt, MD, MPH, authors of Association of Survival With Adherence to the American Cancer...
Standard vs Dose-Escalated Radiotherapy in Medium-Risk Prostate Cancer
15 Mar 2018
Contributed by Lukas
Interview with Jeff Michalski, MD, author of Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Canc...
Atezolizumab Monotherapy for Patients With Metastatic Urothelial Cancer
08 Feb 2018
Contributed by Lukas
Interview with Daniel P. Petrylak, MD, PhD, author of Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term ...
Dietary Inflammatory Potential and Risk of Colorectal Cancer in Men and Women
18 Jan 2018
Contributed by Lukas
Interview with Fred K. Tabung, and Charles S. Fuchs, MD, MPH, authors of Association of Dietary Inflammatory Potential With Colorectal Cancer Risk in...
Preoperative vs Postoperative CEA and Colon Cancer Outcome
21 Dec 2017
Contributed by Lukas
Interview with Martin R. Weiser, MD, author of Association of Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome
Critical Lessons From High-Value Oncology Practices
16 Nov 2017
Contributed by Lukas
Interview with Douglas W. Blayney, MD, author of Critical Lessons From High-Value Oncology Practices
Prophylactic Surgery for Stage IV Small Intestinal Neuroendocrine Tumors
19 Oct 2017
Contributed by Lukas
Interview with Kosmas Daskalakis, MD, author of Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors Wi...
Trends in Adult Cancer–Related Emergency Department Utilization
31 Aug 2017
Contributed by Lukas
Interview with Nonniekaye Shelburne, BSN, MS, and Demetrios Kyriacou, authors of Trends in Adult Cancer–Related Emergency Department Utilization: A...
Prevalence of Cancer in Li-Fraumeni Syndrome Cohort
03 Aug 2017
Contributed by Lukas
Interview with Sharon A. Savage, MD, author of Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohor...
Breast Cancer Due to Non–BRCA1 and Non–BRCA2 Mutations in Ashkenazi Jewish Women
20 Jul 2017
Contributed by Lukas
Interview with Mary-Claire King, author of Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among ...
Trends in Reoperation After Initial Lumpectomy for Breast Cancer
05 Jun 2017
Contributed by Lukas
Interview with Monica Morrow, MD, author of Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Ma...
Combined TMPRSS2:ERG and PCA3 RNA Testing for Detection of Prostate Cancer
18 May 2017
Contributed by Lukas
Interview with Martin G. Sanda, MD, author of Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prost...